Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey

R Kones - Drug design, development and therapy, 2011 - Taylor & Francis
A recent explosion in the amount of cardiovascular risk and incipient, undetected subclinical
cardiovascular pathology has swept across the globe. Nearly 70% of adult Americans are …

Role of the PRMT–DDAH–ADMA axis in the regulation of endothelial nitric oxide production

AJ Pope, K Karuppiah, AJ Cardounel - Pharmacological Research, 2009 - Elsevier
There is abundant evidence that the endothelium plays a crucial role in the maintenance of
vascular tone and structure. One of the major endothelium-derived vasoactive mediators is …

Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome

P Lopez-Jaramillo, RA Sánchez, M Diaz… - Anales Venezolanos …, 2013 - ve.scielo.org
Guía Consenso Latinoamericano de Hipertensión en pacientes con Diabetes tipo 2 y Síndrome
Metabólico1. Latin American consen Page 1 40 An Venez Nutr 2013; 26(1): 40 - 61 Guía …

Asymmetric dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?

G Bouras, S Deftereos, D Tousoulis… - Current topics in …, 2013 - ingentaconnect.com
Asymmetric Dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO)
production. ADMA is generated from methylation of arginine residues by protein arginine …

The prediction of metabolic syndrome alterations is improved by combining waist circumference and handgrip strength measurements compared to either alone

JP Lopez-Lopez, DD Cohen, D Ney-Salazar… - Cardiovascular …, 2021 - Springer
Background Adiposity is a major component of the metabolic syndrome (MetS), low muscle
strength has also been identified as a risk factor for MetS and for cardiovascular disease. We …

Endothelial dysfunction, ADMA and insulin resistance in essential hypertension

F Perticone, A Sciacqua, R Maio, M Perticone… - International journal of …, 2010 - Elsevier
BACKGROUND: Endothelial dysfunction and insulin resistance (IR) are associated with
essential hypertension and other cardiovascular risk factors. Asymmetric dimethylarginine …

Epidemic of cardiometabolic diseases: a Latin American point of view

P Lopez-Jaramillo, V Lahera… - Therapeutic Advances …, 2011 - journals.sagepub.com
Poor early nutrition has varying effects on subsequent cardiometabolic disease (CMD) rates.
Fetal and neonatal periods are critical for the development and growth of the systems …

[HTML][HTML] Consenso latino-americano de hipertensão em pacientes com diabetes tipo 2 e síndrome metabólica

P López-Jaramillo, RA Sánchez, M Diaz… - … de Endocrinologia & …, 2014 - SciELO Brasil
O presente documento foi preparado por um grupo de especialistas, membros das
Sociedades de Cardiologia, Endocrinologia, Medicina Interna, Nefrologia e Diabetes dos …

Connection between telomerase activity in PBMC and markers of inflammation and endothelial dysfunction in patients with metabolic syndrome

E Rentoukas, K Tsarouhas, I Kaplanis, E Korou… - PloS one, 2012 - journals.plos.org
Metabolic syndrome (MS) is a constellation of metabolic derangements associated with
vascular endothelial dysfunction and oxidative stress and is widely regarded as an …

[HTML][HTML] Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico

P López-Jaramillo, RA Sánchez, M Díaz, L Cobos… - Revista Med, 2013 - scielo.org.co
El presente documento ha sido preparado por un grupo de expertos, miembros de las
sociedades de cardiología, endocrinología, medicina interna, nefrología y diabetes de los …